Brief: AAP Implantate sells biomaterials business for EUR 36 mln
22/03/2016 01:21
March 22 (Reuters) - AAP Implantate AG AAQG.DE :
* sells biomaterials business for 36 million euros ($40.46
million) and becomes a pure player in trauma with innovative
technologies
* Closing of the transaction will lead to adjustment of 2016
guidance and postponement of publication of consolidated and
annual financial statements 2015
* The closing of the transaction will result in a positive
one-time deconsolidation effect on the earnings level
* plans to use part of the proceeds to finance further
growth and to distribute part of them to its shareholders
Source text for Eikon: urn:newsml:reuters.com:*:nEQ3xjxpYa
Further company coverage: AAQG.DE
($1 = 0.8898 euros)
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co